Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$9.55
+1.4%
$8.70
$7.11
$11.90
$1.29B1.641.30 million shs4.37 million shs
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$21.49
+0.0%
$22.64
$18.70
$29.55
$1.02B1.82413,514 shs987,616 shs
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
$11.15
+9.5%
$10.88
$3.52
$23.40
$509.30M0.841.97 million shs2.64 million shs
Neogen Corporation stock logo
NEOG
Neogen
$4.73
-1.3%
$5.58
$3.87
$18.58
$1.03B1.843.39 million shs9.28 million shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
+1.38%+13.83%+5.18%-10.24%-2.75%
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
+0.05%+1.27%-3.85%-17.22%0.00%
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
+9.53%+34.99%+4.69%-3.04%+140.82%
Neogen Corporation stock logo
NEOG
Neogen
-1.25%-4.25%-22.59%-45.25%-70.42%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
3.7541 of 5 stars
3.53.00.00.01.51.73.1
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
3.0538 of 5 stars
3.53.00.00.02.72.50.6
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
3.2179 of 5 stars
4.63.00.00.01.80.80.6
Neogen Corporation stock logo
NEOG
Neogen
3.8059 of 5 stars
3.34.00.00.01.13.32.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
3.00
Buy$13.4040.31% Upside
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
3.00
Buy$31.1745.03% Upside
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
3.13
Buy$33.75202.69% Upside
Neogen Corporation stock logo
NEOG
Neogen
2.50
Moderate Buy$9.0090.27% Upside

Current Analyst Ratings Breakdown

Latest CAPR, AHCO, NEOG, and BLFS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2025
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$21.00
6/25/2025
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/25/2025
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$40.00 ➝ $29.00
6/24/2025
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$77.00
6/23/2025
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$43.00 ➝ $22.00
6/17/2025
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$31.00
6/13/2025
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$77.00
5/20/2025
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$31.00
5/14/2025
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$30.00 ➝ $30.00
5/13/2025
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$30.00 ➝ $30.00
5/12/2025
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $13.00
(Data available from 6/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$3.26B0.40$3.79 per share2.52$11.72 per share0.81
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$82.25M12.41$0.12 per share175.41$7.52 per share2.86
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
$22.27M22.87N/AN/A$3.20 per share3.48
Neogen Corporation stock logo
NEOG
Neogen
$924.22M1.11$1.03 per share4.61$14.52 per share0.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$90.42M$0.5716.759.851.102.63%6.96%2.40%8/5/2025 (Estimated)
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$20.18M-$0.29N/AN/AN/A-11.81%-0.66%-0.58%8/14/2025 (Estimated)
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
-$40.47M-$1.42N/AN/AN/A-181.71%-62.42%-48.36%8/6/2025 (Estimated)
Neogen Corporation stock logo
NEOG
Neogen
-$9.42M-$2.23N/A9.65N/A-53.56%2.69%1.82%7/29/2025 (Estimated)

Latest CAPR, AHCO, NEOG, and BLFS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
-$0.33-$0.53-$0.20-$0.53$3.16 million$2.73 million
5/8/2025Q1 2025
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$0.03$0.04+$0.07-$0.01$22.22 million$23.94 million
4/9/2025Q3 2025
Neogen Corporation stock logo
NEOG
Neogen
$0.12$0.10-$0.02-$0.05$225.27 million$221.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
N/AN/AN/AN/AN/A
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
N/AN/AN/AN/AN/A
Neogen Corporation stock logo
NEOG
Neogen
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
1.25
1.29
1.07
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
0.01
4.73
3.74
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
N/A
6.55
6.55
Neogen Corporation stock logo
NEOG
Neogen
0.33
3.91
2.45

Institutional Ownership

CompanyInstitutional Ownership
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
82.67%
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
21.68%
Neogen Corporation stock logo
NEOG
Neogen
96.73%

Insider Ownership

CompanyInsider Ownership
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
1.55%
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.20%
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
10.50%
Neogen Corporation stock logo
NEOG
Neogen
1.13%
CompanyEmployeesShares OutstandingFree FloatOptionable
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
10,500134.95 million132.86 millionOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
44047.50 million46.46 millionOptionable
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
N/A45.68 million40.88 millionOptionable
Neogen Corporation stock logo
NEOG
Neogen
2,110217.04 million214.59 millionOptionable

Recent News About These Companies

Neogen Chemicals Share Price - The Financial Express
Bullish Neogen Insiders Loaded Up On US$1.44m Of Stock

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AdaptHealth stock logo

AdaptHealth NASDAQ:AHCO

$9.55 +0.13 (+1.38%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$9.56 +0.01 (+0.16%)
As of 06/27/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

BioLife Solutions stock logo

BioLife Solutions NASDAQ:BLFS

$21.49 +0.01 (+0.05%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$21.49 0.00 (0.00%)
As of 06/27/2025 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Capricor Therapeutics stock logo

Capricor Therapeutics NASDAQ:CAPR

$11.15 +0.97 (+9.53%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$11.16 +0.00 (+0.04%)
As of 06/27/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Capricor Therapeutics, Inc. (NASDAQ:CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. Capricor's lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy. Capricor has also established itself as one of the leading companies investigating the field of extracellular vesicles and is exploring the potential of CAP-2003, a cell-free, exosome-based candidate, to treat a variety of disorders.

Neogen stock logo

Neogen NASDAQ:NEOG

$4.73 -0.06 (-1.25%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$4.72 -0.02 (-0.32%)
As of 06/27/2025 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.